Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
Clinical trial NCT00283049 · TERMINATED
Trial details
- NCT number
- NCT00283049
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2008-11-01
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.